Triomics
It builds oncology-specific AI software to help cancer centers apply artificial intelligence in cancer care workflows.
Overview
Triomics develops oncology-specific AI for cancer centers, focusing on software tailored to the clinical and operational complexity of cancer care. Its target market is hospitals and cancer centers seeking AI systems built for oncology rather than generic healthcare workflows. The company’s positioning centers on a domain-specific approach to cancer care AI. Triomics raised a $22 million Series B on May 27, 2026, bringing disclosed funding to $22 million across one round.
Funding History
Triomics nabs $22M to bring oncology-specific AI to cancer centers
Frequently Asked Questions
- How much has Triomics raised in total?
- Triomics has raised a total of $22M across 1 funding round.
- Who are Triomics's investors?
- Triomics's investors include Undisclosed.
- What does Triomics do?
- Triomics develops oncology-specific AI for cancer centers, focusing on software tailored to the clinical and operational complexity of cancer care. Its target market is hospitals and cancer centers seeking AI systems built for oncology rather than generic healthcare workflows. The company’s positioning centers on a domain-specific approach to cancer care AI. Triomics raised a $22 million Series B on May 27, 2026, bringing disclosed funding to $22 million across one round.
- Where is Triomics headquartered?
- Triomics is headquartered in San Francisco, USA.
Investors
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.